Genprex在澳大利亚获得Reqorsa基因疗法与PD-L1抗体联合用于癌症治疗的专利保护Genprex Secures Australian Patent for Reqorsa Gene Therapy Combined with PD-L1 Antibodies in Cancer Treatment

动脉网
Feb 10

by GOAI由GOAI生成Share To分享到Genprex has announced that IP Australia intends to grant a patent for its proprietary gene therapy, Reqorsa®, in combination with PD-L1 antibodies for the treatment of cancers...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10